Amouroux C, Lazzaroni J C, Portalier R
Laboratoire de Microbiologie et Génétique Moléculaire (UMR106, CNRS), Université Claude Bernard Lyon I, Villeurbanne, France.
FEMS Microbiol Lett. 1991 Mar 1;62(2-3):305-13. doi: 10.1016/0378-1097(91)90176-b.
tolA mutants of Escherichia coli K-12 release periplasmic proteins into the extracellular medium; they are sensitive to growth inhibitors such as cholic acid and tolerant to group A colicins and filamentous bacteriophage. Suppressor mutants of the tolA-876 allele were isolated by selecting for cholic acid resistant clones that did not release periplasmic ribonuclease I. One class of tolA suppressor strains carried mutations in the staA gene (for suppressor of tolA) located a 41 min. tolA-876 staA strains partially recovered a wild-type phenotype: they exported alkaline phosphatase and beta-lactamase into the periplasm and only released very low amounts of periplasmic proteins; moreover, they were sensitive to E1 and A colicins and more resistant than tolA-876 staA+ strains to various growth inhibitors. Furthermore, tolA-876 staA-2 and tolA+staA-2 mutants were 10- to 2700-times more resistant than staA+ strains to bacteriophages TuIa, TuIb and T4, and TuII whose receptors are major outer membrane proteins OmpF, OmpC and OmpA, respectively. SDS-PAGE analysis suggested that cell envelopes of staA or staA+ strains contained similar amounts of these proteins but characterization of strains carrying ompF (or C or A)-phoA gene fusions showed that mutation stA-2 reduced ompF gene expression by a factor of two. Analysis of double mutants strains carrying mutation staA-2 and a tolA, tolB, excC or excD periplasmic-leaky mutation showed that staA suppression was allele specific which suggested that proteins TolA and StaA might directly interact.
大肠杆菌K - 12的tolA突变体将周质蛋白释放到细胞外培养基中;它们对胆酸等生长抑制剂敏感,对A组大肠杆菌素和丝状噬菌体具有耐受性。通过选择不释放周质核糖核酸酶I的耐胆酸克隆,分离出tolA - 876等位基因的抑制突变体。一类tolA抑制菌株在位于41分钟处的staA基因(tolA的抑制基因)中发生了突变。tolA - 876 staA菌株部分恢复了野生型表型:它们将碱性磷酸酶和β - 内酰胺酶输出到周质中,仅释放极少量的周质蛋白;此外,它们对E1和A大肠杆菌素敏感,并且比tolA - 876 staA +菌株对各种生长抑制剂更具抗性。此外,tolA - 876 staA - 2和tolA + staA - 2突变体对噬菌体TuIa、TuIb和T4以及TuII的抗性比staA +菌株高10至2700倍,这些噬菌体的受体分别是主要外膜蛋白OmpF、OmpC和OmpA。SDS - PAGE分析表明,staA或staA +菌株的细胞包膜中这些蛋白质的含量相似,但对携带ompF(或C或A)- phoA基因融合的菌株进行表征显示,stA - 2突变使ompF基因表达降低了两倍。对携带stA - 2突变和tolA、tolB、excC或excD周质渗漏突变的双突变菌株的分析表明,staA抑制具有等位基因特异性,这表明TolA和StaA蛋白可能直接相互作用。